Skip navigation



Cabume -

Cambridge Business Magazine

Horizon Discovery introduces four BRAF resistant melanoma PDX models

PDX models of tumors offer better in vivo insights for cancer research and drug development. Highly characterized models, originally exclusively licensed from The Wistar Insitute More »
26 May 2017

Wickham Laboratories Announces Upcoming Webinar on In-Vitro Alternatives

Join us for a free webinar to discuss the challenges of transitioning from in-vivo to in-vitro methods More »
25 May 2017

High Efficiency Ozone / UV Sterilizer

AMSBIO announces its new generation laboratory benchtop sterilizer - the CoolCLAVE™ Plus. More »
24 May 2017

Owlstone Medical Establishes Scientific Advisory Board with Appointment of Professor Sir Bruce Ponder

Owlstone Medical, a diagnostics company developing a breathalyzer for disease, announced today the appointment of Professor Sir Bruce Ponder FRCP FMedSci FRS to its newly established Scientific Advisory Board (SAB) with immediate effect. More »
23 May 2017

ATUM Licenses Gene Design Software to Thermo Fisher Scientific

ATUM (formerly DNA2.0, Inc.) announced today that the company has signed a patent licensing agreement that gives Thermo Fisher Scientific access to the company’s novel gene design platform. More »
18 May 2017

Quantum dots to shine bright with ROMIL solvents

ROMIL solvents are helping researchers at the Cavendish Laboratory, the University of Cambridge’s Department of Physics, to develop novel quantum dots which could be used in the next generation of solar panels. More »
18 May 2017

Charles River Laboratories Announces Updates to Oncology Business

Charles River Laboratories International, Inc. (NYSE: CRL) recently announced updates to its expanding oncology discovery business, including significant additions to its online Tumor Model Compendium. More »
17 May 2017


A leading US life sciences firm has doubled its presence in the UK by locating at Imperial College London's White City Campus in west London. More »
17 May 2017

Products for Cell Signaling Studies

AMSBIO has introduced a new range of ready-to-use Reporter Lentivirus for assessing cell signaling activities in virtually any mammalian cell type. More »
16 May 2017

Uttlesford District Council Purchases 50% Share in Chesterford Research Park

Local authority invests in prestigious development to become joint owners alongside Aviva Investors More »
16 May 2017

<< Previous   Page 1 of 27   Next >>